Bunjes D, Theobald M, Hertenstein B, Wiesneth M, Novotny J, Arnold R, Heimpel H
Department of Internal Medicine, Ulm University, Germany.
Bone Marrow Transplant. 1995 May;15(5):713-9.
Six patients treated for relapsed chronic myeloid leukaemia after allogeneic bone marrow transplantation with donor buffy coat transfusions were investigated. In the 5 patients who achieved molecular remission high frequencies of host-reactive interleukin 2-secreting T helper cell precursors (Th-p) were detectable by limiting dilution analysis. In four of the patients the presence of Th-p was associated with a clinical syndrome similar to transfusion GVHD suggesting a T cell response to minor histocompatibility antigens (minor H) expressed by both malignant haemopoiesis and host tissues. In the fifth responding patient no GVHD or bone marrow hypoplasia was observed. The nature of the antigens recognised by these donor Th-p remains unknown. No host-reactive Th-p were detectable in the non-responder and host-reactive cytotoxic T cell precursors (CTL-p) were not consistently detectable in the responding patients.
对6例接受异基因骨髓移植后复发的慢性髓性白血病患者进行了供体白细胞层输注治疗并进行了研究。在通过极限稀释分析可检测到实现分子缓解的5例患者中,宿主反应性白细胞介素2分泌型T辅助细胞前体(Th-p)的频率较高。在4例患者中,Th-p的存在与一种类似于输血性移植物抗宿主病(GVHD)的临床综合征相关,提示对恶性造血和宿主组织表达的次要组织相容性抗原(次要H)产生T细胞反应。在第五例有反应的患者中,未观察到GVHD或骨髓发育不全。这些供体Th-p识别的抗原性质尚不清楚。在无反应者中未检测到宿主反应性Th-p,在有反应的患者中也未始终检测到宿主反应性细胞毒性T细胞前体(CTL-p)。